TYPE 2 DIABETES AND CARDIOVASCULAR COMPLICATIONS: IS IT POSSIBLE TO IMPROVE PROGNOSIS BY GLUCOSE LOWERING THERAPY? ArticleKobalava Z.D., Kiyakbaev G.K.Российский кардиологический журнал. Vol. 23. 2018. P.. 79-91
THE PREVALENCE OF CHRONIC KIDNEY DISEASE MARKERS IN ARTERIAL HYPERTENSION PATIENTS AND RELATION WITH DIABETES: RESULTS OF EPIDEMIOLOGICAL STUDY KHRONOGRAPH ArticleKobalava Z.D., Villevalde S.V., Bagmanova N.K., Batyushin M.M., Orlova G.M.Российский кардиологический журнал. Vol. 23. 2018. P.. 91-101
DEFICIT OF MAGNESIUM AND STATES OF HYPERCOAGULATION: INTELLECTUAL ANALYSIS OF DATA OBTAINED FROM A SAMPLE OF PATIENTS AGED 18-50 YEARS FROM MEDICAL AND PREVENTIVE FACILITIES IN RUSSIA ArticleГромова О.А., Торшин И.Ю., Кобалава Ж.Д., Сорокина М.А., Виллевальде С.В., Галочкин С.А., Гоголева И.В., Грачева О.Н., Гришина Т.Р., Громов А.Н., Егорова Е.Ю., Калачева А.Г., Малявская С.И., Мерай И.А., Семенов В.А.Kardiologiia. Vol. 58. 2018. P.. 22-35
EFFECTS OF GLUCOSE LOWERING DRUGS ON CARDIOVASCULAR RISK IN TYPE 2 DIABETES MELLITUS: REALITIES AND PERSPECTIVES ArticleКобалава Ж.Д., Киякбаев Г.К.Kardiologiia. Vol. 58. 2018. P.. 53-65
PROBLEMS OF ANTICOAGULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION: ROLE OF RIVAROXABAN ArticleКобалава Ж.Д., Виллевальде С.В., Троицкая Е.А.Kardiologiia. Vol. 58. 2018. P.. 33-41
PRACTICAL ASPECTS OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION ArticleКобалава Ж.Д., Шаваров А.А.Kardiologiia. Vol. 58. 2018. P.. 42-55
EXPERIENCE OF HOSPITAL INITIATION OF SACUBITRIL/VALSARTAN IN A FEMALE PATIENT AFTER ACUTE DECOMPENSATED HEART FAILURE ArticleГалочкин С.А., Лукина О.И., Мерай И.А., Виллевальде С.В., Кобалава Ж.Д.Kardiologiia. Vol. 58. 2018. P.. 60-64
SGLT2 INHIBITORS: RATIONALE AND PERSPECTIVES OF USE IN HEART FAILURE ArticleКобалава Ж.Д., Лазарев П.В., Виллевальде С.В.Kardiologiia. Vol. 58. 2018. P.. 44-54
INFECTIVE ENDOCARDITIS IN MOSCOW GENERAL HOSPITAL: CLINICAL CHARACTERISTICS AND OUTCOMES (SINGLE-CENTER 7 YEARS’ EXPERIENCE) ArticleMoiseev V.S., Kobalava Z.D., Pisaryuk A.S., Milto A.S., Kotova E.O., Karaulova Y.L., Kahktsyan P.V., Chukalin A.S., Balatskiy A.V., Safarova A.F., Ratchina S.А., Merai I.A., Povalyaev N.M.Kardiologiia. Vol. 58. 2018. P.. 66-75
PROGNOSTIC VALUE OF LIVER STIFFNESS IN DECOMPENSATED HEART FAILURE: RESULTS OF PROSPECTIVE OBSERVATIONAL TRANSIENT ELASTOGRAPHY-BASED STUDY ArticleSoloveva A.E., Kobalava Z.D., Villevalde S.V., Bayarsaikhan M., Garmash I.V., Fudim M.Kardiologiia. 2018. P.. 20-32
EFFICACY AND TOLERANCE OF ARIFAM IN PATIENTS WITH ARTERIAL HYPERTENSION OVER 55 YEARS OLD: MAIN RESULTS OF THE OBSERVATIONAL PROGRAM ARBALET ArticleKobalava Z.D., Tolkacheva V.V., Bagmanova N.K., Khasanova E.R.Российский кардиологический журнал. Vol. 23. 2018. P.. 64-74
FIXED COMBINATION OF AMLODIPINE/INDAPAMIDE-RETARD IN THE TREATMENT OF UNCONTROLLED HYPERTENSION IN SUBJECTS OVER 55 YEARS OLD ArticleKobalava Zh.D., Shavarova E.K., Khomova I.A., Goreva L.A., Karapetyan L.V.Arterial Hypertension. Vol. 24. 2018. P.. 586-595
ASSOCIATION OF SNPS IN THE PROMOTER REGIONS OF VEGF (RS699947 И RS2010963), ICAM1 (RS281437) AND ET-1 (RS1800541) WITH SERUM LEVELS OF RELATED PROTEINS AND ALCOHOLIC LIVER CIRRHOSIS RISK ArticleIvanov A.S., Garmasch I.V., Arisheva O.S., Markova M.A., Melnik A.S., Terebilina N.N., Baronets V.Yu., Peregud D.I., Tarasenko E.V., Kobalava Z.D.Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. Vol. 73. 2018. P.. 368-377
INCIDENCE AND PROGNOSTIC VALUE OF RESIDUAL CONGESTION BY BIOIMPEDANCE VECTOR ANALYSIS IN PATIENTS WITH DECOMPENSATED HEART FAILURE ArticleBayarsaikhan M., Soloveva A., Villevalde S., Kobalava Z.Journal of Hypertension. Vol. 36. 2018.
VOLUME-COMPRESSIVE OSCILLOMETRY AS NEW BLOOD PRESSURE-MEASURING DEVICE ArticleShavarova E., Padaryan S., Kobalava Z.Journal of Hypertension. Vol. 36. 2018.